Several other analysts have also weighed in on GEVO. HC Wainwright reiterated a buy rating and set a $10.00 target price on shares of Gevo in a research report on Thursday, August 15th. Zacks Investment Research lowered shares of Gevo from a hold rating to a sell rating in a research report on Tuesday, July 2nd.
NASDAQ GEVO opened at $2.58 on Friday. The firm has a market capitalization of $30.68 million, a price-to-earnings ratio of -0.49 and a beta of 2.70. The company’s fifty day moving average is $2.41 and its two-hundred day moving average is $2.26. Gevo has a 52-week low of $1.79 and a 52-week high of $4.97.
In other Gevo news, insider Timothy J. Cesarek bought 25,000 shares of the firm’s stock in a transaction dated Thursday, June 6th. The shares were acquired at an average cost of $1.91 per share, for a total transaction of $47,750.00. Following the transaction, the insider now owns 30,000 shares in the company, valued at $57,300. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 3.41% of the stock is currently owned by insiders.
A hedge fund recently bought a new stake in Gevo stock. Wedbush Securities Inc. purchased a new stake in shares of Gevo Inc (NASDAQ:GEVO) in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 30,500 shares of the energy company’s stock, valued at approximately $67,000. Wedbush Securities Inc. owned about 0.26% of Gevo as of its most recent SEC filing. Institutional investors own 6.91% of the company’s stock.
Gevo, Inc is a renewable chemicals and next generation biofuels company, which focuses on the development and commercialization of renewable alternatives to petroleum-based products. It operates through the following segments: Gevo; Gevo Development and Agri-Energy. The Gevo segment focuses in the research and development activities related to the future production of isobutanol, including the development of the firm’s proprietary biocatalysts, the production and sale of renewable jet and other fuels, the retrofit process, and the next generation of chemicals and biofuels that will be based on the company’s isobutanol technology.
Read More: How does quantitative easing work?
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Gevo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gevo and related companies with MarketBeat.com's FREE daily email newsletter.